Hermann Fritz Requardt - Mar 4, 2024 Form 4 Insider Report for BRUKER CORP (BRKR)

Role: Director
Signature: /s/ Michael A Simone, Attorney-in-Fact
Stock symbol: BRKR
Transactions as of: Mar 4, 2024
Transactions value $: -$1,020,148
Form type: 4
Date filed: 3/6/2024, 04:05 PM
Previous filing: Jan 9, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BRKR	Common Stock	Options Exercise	$90.8K	+5K	+21.6%	$18.15^*	28.1K	Mar 4, 2024	Direct
transaction	BRKR	Common Stock	Options Exercise	$240K	+10K	+35.53%	$24.00^*	38.1K	Mar 4, 2024	Direct
transaction	BRKR	Common Stock	Sale	-$1.24M	-13.8K	-36.1%	$90.10	24.4K	Mar 4, 2024	Direct	F1
transaction	BRKR	Common Stock	Sale	-$110K	-1.23K	-5.04%	$89.61	23.1K	Mar 4, 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BRKR	Stock Option (Right to Purchase)	Options Exercise	$0	-5K	-100%	$0.00^*	0	Mar 4, 2024	Common Stock	5K	$18.15	Direct	F3
transaction	BRKR	Stock Option (Right to Purchase)	Options Exercise	$0	-10K	-100%	$0.00^*	0	Mar 4, 2024	Common Stock	10K	$24.00	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.70, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.60 to $89.64, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The stock option granted to the Reporting Person on August 25, 2015 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.
F4	The stock option granted to the Reporting Person on January 5, 2016 (the "Original Grant Date") vests in equal installments on the first, second, third and fourth anniversaries of the Original Grant Date.